Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence
Despite recent advances in cancer therapeutics, pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year overall survival of only 10%. Since either at or within a few months of diagnosis, most patients with PDAC will present with metastatic disease, a more individualized approa...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Cancer Biology & Therapy |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15384047.2023.2198479 |